148 related articles for article (PubMed ID: 10513855)
41. Case of gynecomastia during paroxetine therapy.
Damsa C; Sterck R; Schulz P
J Clin Psychiatry; 2003 Aug; 64(8):971. PubMed ID: 12927018
[No Abstract] [Full Text] [Related]
42. Antidepressant-induced sexual dysfunction during treatment with moclobemide, paroxetine, sertraline, and venlafaxine.
Kennedy SH; Eisfeld BS; Dickens SE; Bacchiochi JR; Bagby RM
J Clin Psychiatry; 2000 Apr; 61(4):276-81. PubMed ID: 10830148
[TBL] [Abstract][Full Text] [Related]
43. [Paroxetine versus clomipramine in female adolescents suffering from anorexia nervosa and depressive episode--a retrospective study on tolerability, reasons for discontinuing the antidepressive treatment and different outcome measurements].
Strobel M; Warnke A; Roth M; Schulze U
Z Kinder Jugendpsychiatr Psychother; 2004 Nov; 32(4):279-89. PubMed ID: 15565897
[TBL] [Abstract][Full Text] [Related]
44. Paroxetine response and tolerability among ethnic minority patients with mood or anxiety disorders: a pooled analysis.
Roy-Byrne PP; Perera P; Pitts CD; Christi JA
J Clin Psychiatry; 2005 Oct; 66(10):1228-33. PubMed ID: 16259535
[TBL] [Abstract][Full Text] [Related]
45. Cognitive and psychomotor effects of paroxetine and sertraline on healthy elderly volunteers.
Furlan PM; Kallan MJ; Ten Have T; Pollock BG; Katz I; Lucki I
Am J Geriatr Psychiatry; 2001; 9(4):429-38. PubMed ID: 11739070
[TBL] [Abstract][Full Text] [Related]
46. Fluoxetine versus sertraline and paroxetine in major depression: tolerability and efficacy in anxious depression.
Fava M; Rosenbaum JF; Hoog SL; Tepner RG; Kopp JB; Nilsson ME
J Affect Disord; 2000 Aug; 59(2):119-26. PubMed ID: 10837880
[TBL] [Abstract][Full Text] [Related]
47. Personality changes in adult subjects with major depressive disorder or obsessive-compulsive disorder treated with paroxetine.
Brody AL; Saxena S; Fairbanks LA; Alborzian S; Demaree HA; Maidment KM; Baxter LR
J Clin Psychiatry; 2000 May; 61(5):349-55. PubMed ID: 10847309
[TBL] [Abstract][Full Text] [Related]
48. Post-treatment emergent adverse events in depressed patients following treatment with milnacipran and paroxetine.
Vandel P; Sechter D; Weiller E; Pezous N; Cabanac F; Tournoux A; Panconi E
Hum Psychopharmacol; 2004 Dec; 19(8):585-6. PubMed ID: 15570574
[No Abstract] [Full Text] [Related]
49. It's an ill pill.
Friedli L
Ment Health Today; 2004 May; ():8-9. PubMed ID: 15192924
[No Abstract] [Full Text] [Related]
50. Tolerability of combined treatment with lithium and paroxetine in patients with bipolar disorder and depression.
Fagiolini A; Buysse DJ; Frank E; Houck PR; Luther JF; Kupfer DJ
J Clin Psychopharmacol; 2001 Oct; 21(5):474-8. PubMed ID: 11593071
[TBL] [Abstract][Full Text] [Related]
51. Paxil (paroxetine) lifts depression, lowers associated anxiety symptoms.
Adv Nurse Pract; 1997 Oct; 5(10):71. PubMed ID: 9459990
[No Abstract] [Full Text] [Related]
52. Platelet reactivity in depressed patients treated with paroxetine: preliminary findings.
Musselman DL; Marzec UM; Manatunga A; Penna S; Reemsnyder A; Knight BT; Baron A; Hanson SR; Nemeroff CB
Arch Gen Psychiatry; 2000 Sep; 57(9):875-82. PubMed ID: 10986551
[TBL] [Abstract][Full Text] [Related]
53. Effect of paroxetine on seizure length during electroconvulsive therapy.
Curran S
Acta Psychiatr Scand; 1995 Sep; 92(3):239-40. PubMed ID: 7484206
[TBL] [Abstract][Full Text] [Related]
54. Discontinuation symptoms: comparison of brief interruption in fluoxetine and paroxetine treatment.
Judge R; Parry MG; Quail D; Jacobson JG
Int Clin Psychopharmacol; 2002 Sep; 17(5):217-25. PubMed ID: 12177584
[TBL] [Abstract][Full Text] [Related]
55. Spotlight on paroxetine in psychiatric disorders in adults.
Wagstaff AJ; Cheer SM; Matheson AJ; Ormrod D; Goa KL
CNS Drugs; 2002; 16(6):425-34. PubMed ID: 12027788
[TBL] [Abstract][Full Text] [Related]
56. Paroxetine-induced anorexia in a patient with bulimia nervosa.
Sagduyu K
J Clin Psychiatry; 1997 May; 58(5):220-1. PubMed ID: 9184619
[No Abstract] [Full Text] [Related]
57. Successful paroxetine treatment of major depression in an adult form of metachromatic leukodystrophy with cognitive disturbances.
Vella G; Loriedo C; Raccah R; Baldassarre P; Paolillo A
Can J Psychiatry; 1998 Sep; 43(7):748-9. PubMed ID: 9773228
[No Abstract] [Full Text] [Related]
58. Efficacy and tolerability of controlled-release and immediate-release paroxetine in the treatment of depression.
Golden RN; Nemeroff CB; McSorley P; Pitts CD; Dubé EM
J Clin Psychiatry; 2002 Jul; 63(7):577-84. PubMed ID: 12143913
[TBL] [Abstract][Full Text] [Related]
59. Change in cognitive functioning following acute antidepressant treatment in late-life depression.
Culang ME; Sneed JR; Keilp JG; Rutherford BR; Pelton GH; Devanand DP; Roose SP
Am J Geriatr Psychiatry; 2009 Oct; 17(10):881-8. PubMed ID: 19916207
[TBL] [Abstract][Full Text] [Related]
60. Antidepressive treatment with amitriptyline and paroxetine: comparable effects on heart rate variability.
Lederbogen F; Gernoth C; Weber B; Colla M; Kniest A; Heuser I; Deuschle M
J Clin Psychopharmacol; 2001 Apr; 21(2):238-9. PubMed ID: 11270923
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
